rx 821002 has been researched along with naltrindole in 1 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (naltrindole) | Trials (naltrindole) | Recent Studies (post-2010) (naltrindole) |
---|---|---|---|---|---|
317 | 0 | 45 | 801 | 0 | 139 |
Protein | Taxonomy | rx 821002 (IC50) | naltrindole (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0007 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gray, AM; Nevinson, MJ; Sewell, RD | 1 |
1 other study(ies) available for rx 821002 and naltrindole
Article | Year |
---|---|
The involvement of opioidergic and noradrenergic mechanisms in nefopam antinociception.
Topics: Abdominal Pain; Acetic Acid; Adrenergic alpha-Antagonists; Analgesics; Analgesics, Non-Narcotic; Animals; Clonidine; Dose-Response Relationship, Drug; Drug Interactions; Idazoxan; Injections, Intraventricular; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Nefopam; Pain Measurement; Receptors, Adrenergic; Receptors, Opioid | 1999 |